公开(公告)号：US20130203767A1

公开(公告)日：2013-08-08

申请号：US13826769

申请日：2013-03-14

Applicant: Pfizer Inc.

Inventor： Ghazwan Saleem Butrous ,  Timothy Michael Lukas ,  Ian Machin

IPC: A61K31/519

CPC classification number: A61K31/519 ,  A61K31/496 ,  A61K31/501 ,  A61K31/517 ,  A61K31/53

Abstract: This invention relates to the use of certain cyclic guanosine 3′,5′-monophosphate phosphodiesterase type five (cGMP PDE5) inhibitors, including in particular the compound sildenafil, for the treatment of pulmonary hypertension.